A5087424876- Gestational Diabetes Research and Management
- Diabetes Management and Research
- Metabolism, Diabetes, and Cancer
- Diabetes Treatment and Management
- Pregnancy and preeclampsia studies
- Diabetes and associated disorders
- Nutrition and Health Studies
- Bariatric Surgery and Outcomes
- Pancreatic function and diabetes
- Diet and metabolism studies
- Diabetes Management and Education
- Adipose Tissue and Metabolism
- Diet, Metabolism, and Disease
- Reproductive System and Pregnancy
- Thermoregulation and physiological responses
- Cancer Risks and Factors
- Birth, Development, and Health
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetic Foot Ulcer Assessment and Management
- Sirtuins and Resveratrol in Medicine
- Breastfeeding Practices and Influences
- Pregnancy and Medication Impact
- Cardiovascular Issues in Pregnancy
- Obesity and Health Practices
- Liver Disease Diagnosis and Treatment
Medical University of Lodz
2015-2025
O2 Czech Republic (Czechia)
2024
InGen (France)
2024
Albert Einstein College of Medicine
2023
Central Clinical Hospital
2021
Centralny Szpital Kliniczny
2016
Polish Mother’s Memorial Hospital Research Institute
1999-2015
Diabetes UK
2015
Children's Hospital at Westmead
2013
Memorial Hospital
2008
Conflict of
The 2019 Diabetes Poland guidelines -summary of the most important changes Since 2005, (PTD, Polskie Towarzystwo Diabetologiczne) prepares and publishes annually its on management diabetic patients.The idea guideline development was first suggested in 2004 by Prof. Jacek Sieradzki who president PTD at that time.The chairperson Guideline Writing Group Władysław Grzeszczak acted this capacity 2005-2011, followed next PTD, 2011-2015, Leszek Czupryniak.The are a product team nearly 50 experts...
To compare the efficacy and safety of dapagliflozin plus saxagliptin vs glimepiride as add-on to metformin in patients with type 2 diabetes.
2022 Guidelines on the management of patients with diabetes A position Diabetes Poland Rules for diagnosing carbohydrate metabolism disordersKey recommendations• Blood sugar tests early detection prediabetes/type 2 should be performed people over 45, as well younger overweight or obese if there is at least one additional risk factor diabetes.[B]• Women not previously diagnosed undergo an oral glucose tolerance test between 24 th and 28 week pregnancy to diagnose gestational diabetes.[A]•...
Adenosine receptors denoted by A1 , A2A A2B and A3 encoded ADORA1, ADORA2A, ADORA2B, ADORA3 genes, respectively, are adenosine-activated G-protein-coupled that play an important role in obesity type 2 diabetes mellitus. However, little is known about their significance gestational mellitus (GDM). The purpose of this study was to investigate whether there changes leukocyte AR expression GDM patients these alterations linked well-known diabetic genes.Leukocytes were isolated from the blood...
This paper describes a new technique for noninvasive diagnostic analysis of metabolic regulation and the microcirculation. Flow Mediated Skin Fluorescence (FMSF) is based on monitoring intensity NADH fluorescence emitted from skin tissue forearm. The principles are discussed, in particular, concerning experimental procedures definition interpretation measured parameters. unique features potential avenues development FMSF also outlined.
OBJECTIVE To compare the risk of severe adverse pregnancy complications in women with preexisting diabetes. RESEARCH DESIGN AND METHODS Multinational, prospective cohort study to assess prevalence newborns free from major congenital malformations or perinatal neonatal death (primary end point) following treatment insulin detemir (detemir) versus other basal insulins. RESULTS Of 1,457 included, 727 received and 730 The was similar between (97.0%) insulins (95.5%) (crude difference 0.015 [95%...
Gestational diabetes mellitus (GDM) is a disorder which manifests itself for the first time during pregnancy and mainly connected with glucose metabolism. It also known that fatty acid profile changes in erythrocyte membranes plasma could be associated obesity insulin resistance. These factors can lead to development of diabetes. In reported study, we applied untargeted analysis GDM against standard glucose-tolerant (NGT) women identify differences metabolomic profiles between those groups....
Abstract Aims To assess the efficacy and safety of switching from premixed insulin to a once‐daily, fixed‐ratio combination glargine 100 U/mL + lixisenatide (iGlarLixi) in people with type 2 diabetes (T2D). Methods In this phase 4, 24‐week, single‐arm study, participants switched once‐daily or twice‐daily iGlarLixi (EudraCT number 2021–003711‐25). Key inclusion criteria: ≥18 years; therapy for ≥3 months < 10 ± 1–2 oral antidiabetic drugs (OADs); HbA1c ≥7.5% ≤10.0%. The primary endpoint...
Gestational diabetes mellitus (GDM) and type 2 (DM2) are suggested to be caused by the same metabolic disorder. Defects in gut hormone-dependent regulation of beta-cell function (entero-insular axis) have been proposed contribute pathogenesis DM2. The aim study was evaluate whether an impaired secretion glucagon-like peptide-1 (GLP-1) and/or glucose-dependent insulinotropic polypeptide (GIP) could play a role development carbohydrate disorders during pregnancy.The group consisted 13...
Problem Cytokines, advanced glycation end products (AGEs), and their receptor RAGE have been recently suggested to play a role in human pregnancy. In this study, we sought determine the alterations of plasma AGEs, soluble (sRAGE), proinflammatory cytokines normal pregnancies those complicated with type 1 diabetes mellitus. Method study These parameters were measured samples from healthy non‐pregnant (C), diabetic (D), pregnant (HP), (DP) women. Results first trimester, DP showed lower sRAGE...
Compelling evidence indicates that the immune system is linked to metabolism in gestational diabetes mellitus (GDM), but factors participating these processes still are awaiting identification. Inducible nitric oxide synthase, encoded by NOS2 gene, and surfactant protein D, SFTPD have been implicated diabetes. We investigated mRNA levels leukocytes obtained from 125 pregnant women with ( n = 87) or without (control group; 38) GDM, and, turn, correlated their expression clinical parameters of...
The aim of the study was to compare diabetes control and obstetrical outcomes in pregnant women with type 1 treated during pregnancy either continuous subcutaneous insulin infusion (CSII) or multiple daily injections (MDII).It a descriptive, retrospective, observational 116 Caucasian mellitus. Thirty were (CSII group) 86 (MDII group).Mean age body mass index did not differ between groups (p >0.05). Duration longer CSII than MDII group, 12.7 +/- 7.20 vs. 7.71 6.13 years, respectively =...